Maes Michael
IMPACT Strategic Research Center, Barwon Health, Deakin University, Geelong, Vic, Australia.
Neuro Endocrinol Lett. 2015;36(4):320-9.
Chronic fatigue syndrome (CFS) or Myalgic Encephalomyelitis (ME) is characterized by neuro-psychiatric (e.g. depression, irritability, sleep disorders, autonomic symptoms and neurocognitive defects) and physio-somatic (fatigue, a flu-like malaise, hyperalgesia, irritable bowel, muscle pain and tension) symptoms. New ME/CFS case definitions based on consensus criteria among experts are largely inadequate, e.g. those of the US Institute of Medicine .
The aim of the present study was to delineate a new case definition of ME/CFS based on pattern recognition methods and using neuro-immune, inflammatory, oxidative and nitrosative stress (neuro-IO&NS) biomarkers as external validating criteria.
We measured the 12-item Fibromyalgia and Chronic Fatigue Syndrome Rating (FF) Scale in 196 subjects with CFS (CDC criteria) and 83 with chronic fatigue. The "Neuro-IO&NS" biomarkers were: IgM / IgA responses against LPS of gut commensal bacteria (leaky gut), IgM responses to O&NS modified neoepitopes, autoimmunity to serotonin, plasma interleukin-1 (IL-1) and serum neopterin.
Cluster analysis showed the presence of two well-separated clusters with highly significant differences in symptoms and biomarkers. The cluster with higher scores on all FF items was externally validated against all IO&NS biomarkers and therefore this diagnostic group was labeled "Neuro-IO&NS Fatigue" or "Neuro-Inflammatory and Oxidative Fatigue" (NIOF). An algorithm was constructed which defined NIOF as chronic fatigue and 4 or more of the following 6 symptoms: muscle tension, memory disturbances, sleep disorders, irritable bowel, headache or a flu-like malaise. There was a significant overlap between NIOF and CFS although NIOF criteria were much more restrictive. Factor analysis showed two factors, the first a fatigue-hyperalgesia (fibromyalgic complaints) and the second a fatigue-depression factor.
慢性疲劳综合征(CFS)或肌痛性脑脊髓炎(ME)的特征为神经精神症状(如抑郁、易怒、睡眠障碍、自主神经症状和神经认知缺陷)以及身心症状(疲劳、类似流感的不适、痛觉过敏、肠易激、肌肉疼痛和紧张)。基于专家共识标准的新的ME/CFS病例定义在很大程度上并不充分,例如美国医学研究所的定义。
本研究的目的是基于模式识别方法并使用神经免疫、炎症、氧化和亚硝化应激(神经IO&NS)生物标志物作为外部验证标准,来界定ME/CFS的新病例定义。
我们对196名符合CFS(疾病控制与预防中心标准)的受试者和83名患有慢性疲劳的受试者进行了12项纤维肌痛和慢性疲劳综合征评定(FF)量表的测量。“神经IO&NS”生物标志物包括:针对肠道共生菌脂多糖的IgM / IgA反应(肠漏)、对氧化和亚硝化应激修饰新表位的IgM反应、对血清素的自身免疫、血浆白细胞介素-1(IL-1)和血清蝶呤。
聚类分析显示存在两个明显分开的聚类,其症状和生物标志物存在高度显著差异。在所有FF项目上得分较高的聚类通过所有IO&NS生物标志物进行了外部验证,因此该诊断组被标记为“神经IO&NS疲劳”或“神经炎症和氧化疲劳”(NIOF)。构建了一种算法,将NIOF定义为慢性疲劳以及以下6种症状中的4种或更多:肌肉紧张、记忆障碍、睡眠障碍、肠易激、头痛或类似流感的不适。尽管NIOF标准更为严格,但NIOF和CFS之间存在显著重叠。因子分析显示两个因子,第一个是疲劳-痛觉过敏(纤维肌痛性主诉)因子,第二个是疲劳-抑郁因子。